Mirjam Mol-Arts

Mirjam Mol-Arts

Executive Vice President, Chief Medical and Science Officer

Mirjam joined Ferring Pharmaceuticals in January 2018 and has held the role of Chief Medical and Science Officer since July 2020. She is responsible for overseeing Ferring´s Research & Development, Real World Evidence, Global Pharmacovigilance and Global Medical Affairs activities.

Mirjam has over 30 years of global experience in a number of roles across research, medical, clinical development and portfolio management, and joined Ferring as Senior Vice President for Global Development. Prior to joining Ferring, Mirjam held senior leadership positions at Solvay Pharmaceuticals, Schering-Plough, Organon, and MSD . Most recently, she was Chief Executive Officer of a newly-formed science park, which focused on pharmaceutical innovation in the Netherlands.

Mirjam is a qualified medical doctor who graduated with honors from Utrecht University in the Netherlands. She has experience in many therapeutic areas including fertility, contraception, menopause, women´s health, osteoporosis, neurology and dermatology.

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

OK